Effects of Granulocyte-Colony-Stimulating Factor in Neutropenic AIDS-Patients by Goebel, Frank-Detlef et al.
Proceedings of the 1st International Congress on 
Vitamins and Biofactors in Life Science 
in Kobe, 1991 
Special Issue, 1992 




C E N T E R FOR ACADEMIC PUBLICATIONS JAPAN 
C O N T E N T S 
Plenary Lectures 
Biosynthesis and Functions of Glutathione, an Essential Biofactor 
A . MEISTER 1 
The Family of Protein Kinase C in Transmembrane Signalling 
for Cellular Regulation 
Y . A S A O K A , K .YOSHIDA, M . O K A , T.SHINOMURA, H . K O I D E , K . O G I T A , 
U . Κ IKK AW A , and Y . N I S H I Z U K A , 7 
Vitamin B ] 2 - Transport and Hemopoietic Role 
K . O K U D A 13 
Mechanism of Action of 1,25-Dihydroxyvitamin D on Target Gene Expression 
H . F . D E L U C A , H . M . D A R W S H , T.K.Ross, and V.E.Moss 19 
Carotenoids and Tocopherols as Antioxidants and Singlet Oxygen Quenchers 
H.SIES 27 
Microorganisms in Vitamin and Biofactor Research 
E . E .SNELL 34 
How and Why Are Some Riboflavin Coenzymes Covalently 
Attached to Proteins? 
K.DECKER 40 
Biochemical and Molecular Genetic Aspects of Eukaryotic Pyruvate 
Dehydrogenase Multienzyme Complexes 
L . J . R E E D , J .E .LAWSON, X . - D . N I U , M . A . Y A Z D I , and S.P.M.FUSSEY 46 
Membrane Transport of Folate Compounds 
F. M.HUENNEKENS, K.S .VITOUS, L .E .POPE, and J . F A N 52 
Biosynthesis and Functions of Selenoenzymes 
T . C . S T A D T M A N 58 
Vitamin Ε Status in Children-Health and Diseases 
Μ. M I N O 64 
Symposium φ New Horizon in the Research on Vitamin D Metabolism and Functions 
1,25-Dihydroxyvitamin D3 Regulation of Cell Replication and Differentiation 
J.A EISMAN 71 
Further Metabolism of 1 a, 25-Dihydroxyvitamin D3 in Target Cells 
D.LOHNES and G.JONES 75 
Evolutionary Biology and Pathology of Vitamin D 
M . F . H O L I C K 79 
— 1 -
1, 25-Dihydroxy vitamin D3 for the Treatment of Psoriasis 
M . F . H O L I C K , A . P E R E Z , and R . R A A B 84 
Tissue-Specific Production of the Third Component of Complement(C3) 
by Vitamin D in Bone 
E . A B E , C . H . J I N , M . H . H O N G , T .SATO, T . S H I N K I , and T . S U D A 88 
Phosphate Administration Enhances the Action of 1, 25(OH) 2D3 
in Familial Hypophosphatemic Vitamin D Resistant Rickets 
Y.SEINO, H . T A N A K A , and K . Y A M A O K A 92 
Renal Osteodystrophy and Vitamin D Derivatives: Cellular Mechanisms 
of Hyperparathyroidism in Uremia 
Μ. FUKAG AW A , and K . K U R O K A W A 96 
Molecular Cloning of cDNAs Encoding Vitamin D 3 25-Hydroxylase 
and 25-Hydroxyvitamin D3 24-Hydroxylase 
K . O K U D A , Y . O H Y A M A , E . U S U I , andM.NosHiRO 100 
Syposium φ Vitamin B12—Challenges for the Future 
Vitamin Bi 2(Cobalamin) Contents of Serum and Organs in Various 
Diseases and Its Clinical Significance 
N . T A N A K A 104 
Mechanism of Cobalamin Absorption: Intrinsic Factor and Its Receptor 
R.GRÄSBECK, and J . L . G U E A N T 110 
Serum B J 2 Binding Proteins Versus Seminal Plasma Binder 
M . F U K U D A , and S . Y A M A D A 114 
Effects of Methyl Vitamin B I 2 on Sperm Quality 
S.OSHIO, T . Y A Z A K I , and T . U M E D A 118 
Diabetic Neuropathy and Vitamin B i 2 
S.YAGIHASHI 122 
Sleep-Wake Rhythm Disorders and Vitamin Β12 
K . T A K A H A S H I , M.SUGISHITA, and M . O K A W A 126 
New Approaches to the Diagnosis of Cobalamin (Cbl, Vitamin B J 2 ) 
Deficiency in Neuropsychiatry Disorders 
R . H . A L L E N , S.P.STABLER, D.G.SAVAGE, and J .LINDENBAUM 150 
Syposium φ Eicosapentaenoic Acid—Physiology and Pathology 
Reactivities of Mammalian Lipoxygenases with Various Polyunsaturated 
Fatty Acids 
Y . T A K A H A S H I , T . H A D A , N . U E D A , and S .YAMAMOTO i;-4 
The Effects of Fish Oil on Glucose Transport Systems 
H . I T A K U R A , O . E Z A K I , and E.TSUJI K8 
— 2 — 
Clinical and Epidemiological Study of Eicosapentaenoic Acid (EPA) in Japan 
Y . T A M U R A , A . H I R A I , T . T E R A N O , H . S A I T O H , and S.YOSHIDA 140 
Cardiovascular Effects of N - 3 Fatty Acids 
P . C . W E B E R , and A . S E L L M A Y E R 144 
n-3 Fatty Acids: Biochemical Actions in Cancer 
R . Κ ARM A L I 148 
Docosahexaenoic Acid is an Essential Nutrient in the Nervous System 
N . S A L E M Jr., and R.J .PAWLOSKY 153 
Symposium ® Recent Vitamin C Research and Human Health Benefits 
Role of Vitamin C in Basement Membrane Synthesis and Cell Differentiation 
Υ . Κ I T AG AW A 157 
Bioavailability and Biological Activity of L-Ascorbic Acid 2-O-a-Glucoside 
I . Y A M A M O T O a n d N . M u T O 161 
Nutritional Significance of Ascorbic Acid for the Metabolism of Xenobiotics 
and Cholesterol in ODS- and Conventional Rats 
F . H O R I O , N .MATSUSHITA and A . YOSHIDA 165 
Ascorbic Acid and Reaction Kinetics in situ:A New Approach to Vitamin 
Requirements 
M . L E V I N E , K . R . D H A R I W A L , P .WASHKO, R . W E L C H , Y - Η W A N G , 
C. C.CANTILENA, and R . Y u 169 
Recommended Dietary Allowance: Support from Recent Research 
D . HORNIG and F.STROLZ 173 
Symposium (§) Vitamin Ε : Approach to Atherosclerosis 
Vitamin Ε and Atherosclerosis:An Overview 
H.ESTERBAUER, H . P U H L , G . W A E G , A . K R E B S , F.TATZBER, and H . R A B L 177 
Role of Lipid Peroxidation and Antioxidants in Atherogenesis 
S.PARTHASARATHY 183 
Prevention of Aortic Calcification in Patients on Hemodialysis by Long-Term 
Administration of Vitamin Ε 
S . Y U K A W A , M.SONOBE, Y . T O N E , A . Y U K A W A , K . M I M U R A , M . M U N E , T . M A E D A , 
H . N O M O T O , and I . N I S H I D E 187 
Alpha-Tocopherol: A Potent Inhibitor of Platelet Adhesion 
M . STEINER 191 
Atherosclerosis from a Viewpoint of Arterial Wall Cell Function: Relation 
to Vitamin Ε 
N . M O R I S A K I , K . Y O K O T E , and Y . S A I T O 196 
— 3 — 
Lipid Peroxidation, Vitamin E, and Cardiovascular Disease 
J . M U S I A L , T . B . D O M A G A L A , and A .SZCZEKLIK 200 
A Prevention Trial on Cerebral Infarction with dl-a-Tocopheryl Nicotinate 
— Rationales for Trial — 
Y . H A T A , A . T E R A S H I , T . M A T S U Z A K I , E . O H T O M O , and Y . G O T O 204 
Symposium ® Vitamin B2 and P Q Q 
Uptake and Metabolism of 4'(N)-Substituted Pyridoxamines by Cells from the Liver 
and Kidneys of Rats 
Z . Z H A N G , and D . B . M C C O R M I C K 208 
B6-Enzymes Participating in D-Amino Acid Metabolism 
K . S O D A 212 
Aspartate Aminotransferase of E.coli: Effects of Site-Directed Mutagenesis 
on Substrate Recognition 
Η . Κ AG A M I Υ ΑΜΑ 2 1 6 
The Quinoid Cofactors, Pyrroloquinoline Quinone(PQQ), Topaquinone (TPQ) 
and Tryptophan Tryptophylquinone (TTQ) 
J . A . D U I N E 220 
Biochemistry and Physiology of Pyrroloquinoline Quinone and Quinoprotein 
Dehydrogenases 
O . A D A C H I , K.MATSUSHITA, and M . A M E Y A M A 224 
Symposium ® Aging and Vitamins 
Vitamin A : Differentiating Action on Gastric Cancer Cells and Gastric Mucosal 
Cells in Elderly People 
T . C H I B A , and N . A R I M A 228 
Role of the Active Vitamin D Metabolite and 1 α-Hydroxylated Analogs 
in the Treatment of Postmenopausal Osteoporosis 
A . C A N I G G I A , F . L O R E , R . N U T I , G . M A R T I N I , B . F R E D I A N I , and G.Di CAIRANO 232 
Aging on the Photobiology of Vitamin D3 
M . F . H O L I C K , Z . L u , and T . C . C H E N 236 
Aging of the Brain and Vitamin Ε 
M . T A N A K A , A.SOTOMATSU, and S.HIRAI 240 
Symposium (8) Biotechnology of Biofactors 
Microbial Production of Vitamins and Biofactors: An Overview 
E . J . V A N D A M M E 244 
Beta-Carotene Production Using Algal Biotechnology 
L.J .BOROWITZKA 248 
Microbial Process of Menaquinone Production 
Y . T A N I 251 
Production of Polyunsaturated Fatty Acids by Microorganisms 
H . Y A M A D A , S.SHIMIZU, Y .SHINMEN, K . A K I M O T O , and H . K A W A S H I M A 255 
— 4 — 
Microbial Production of Vitamin B 2 
M . T . Ö Z B A S 259 
Biotin Production by Using Recombinant D N A Technology 
O . I F U K U , S . H A Z E , J .KISHIMOTO, and M . Y A N A G I 263 
Symposium (9) Role of Bioactors as Biomodulator 
Biological Roles of Mono- and Poly(ADP-Ribosyl) ation 
K . U E D A , M.BANASIK, I .SAITO, T . K I D O , B . R . D A S , N . A . N . A B E D , and H . K O M U R A ·· 267 
Endogenous Arginine-Specific ADP-Ribosyltransferases and Target Proteins 
M . S H I M O Y A M A , and M.TSUCHIYA 2 7 1 
The Small G Protein Superfamily - Possible Functions and Modes of Action 
K . K A I B U C H I , A . K I K U C H I , M . K A W A T A , andY .TAKAi 275 
Biomodulators of Glucocorticoid: Amplifiers and Suppressors of Glucocorticoid 
Action 
H . K I D O , andN.KATUNUMA 279 
The Relationship of Protein Nutrition to Protein Turnover 
H . L . S E G A L 283 
Thiamin Pyrophosphate: Catalytic Mechanism, Role in Protein Turnover 
H . H O L Z E R , and C .GUBLER 287 
Cystatins as Regulators of Intracellular Proteolysis 
V . T U R K 292 
Role of Ginsenosides as Bioreactor in Lipid Metabolism 
C.-N.Joo 298 
Role of Substrate in Catecholamine-induced Lipolysis in Rat Fat Cells 
H . O K U D A , H . N I N O M I Y A , C .MORIMOTO, and T.TSUJITA 302 
Relationship between O2- Generation in situ and Histopathological Findings 
in the Colon of Rats Treated with Ischemia-Reperfusion 
K . T A M U R A , M . Y A M A M U R A , S .FUKUI , M . S A T O M I , and T .SHIMOYAMA 306 
Hydroxyl Radical Generation from Heart Mitochondria Damaged by Ischemia 
R.OGURA 309 
Symposium ® Vitamin and Biofactors against Carcinogenesis 
Vitamins and Carcinogenesis: An Overview 
R . E . O L S O N 3 1 3 
Retinoids and Cancer Chemoprevention 
H . M O R I W A K I , andT .MuTO 3 1 7 
Carotenoids in Cancer Chemoprevention and Therapeutic Interventions 
L.SANTAMARIA, and A . B I A N C H I - S A N T A M A R I A 3 2 1 
— 5 — 
Cellular Uptake of Vitamin A 
R.Blomhoff, H.Senoo, S.Smeland, T.Bjerknes, and K . R . N O R U M 327 
Suppression of Colonic Carcinogenesis by Vitamin D in Rats 
A . K A W A U R A , T . T A N I D A , K . S A W A D A , M . O D A , and T .SHIMOYAMA 331 
Marine Natural Products against Tumor Development 
J. YATSUNAMI, H . F U J I K I , A . K O M O R I , M . S U G A N U M A , S.NISHIWAKI, S .OKABE, 
R.NISHIWAKI-MATSUSHIMA, T . O H T A , S.MATSUNAGA, N.FUSETANI, 
and T.SUGIMURA 333 
Symposium © Progress in G - C S F : Basic and Clinical Aspects 
Structure of G-CSF: Significance of the Sugar Chain 
M . O N O , M . O H E D A , S . K A M A C H I , M . K A T O , Y . E N D O , and N . O C H I 337 
Receptor for Granulocyte Colony-Stimulating Factor 
S.NAGATA, and R .FUKUNAGA 341 
Pathophysiological Roles of G-CSF 
K . O Z A W A , K . W A T A R I , T .TSURUTA, S .TAKAHASHI, H . O G U R A , T.YOSHIKUBO, 
M . N I S H I K A W A , M . S H I M A N E , S.OKAMOTO, A . T O J O , K . T A N I , and S.ASANO 345 
Clinical Use of Recombinant Human G-CSF. Aplastic Anemia ( A A ) 
and Myelodysplasie Syndromes (MDS) 
Y . Y O S H I D A , S.ASANO, K . H I R A S H I M A , and F . T A K A K U 349 
Recombinant Granulocyte Colony-stimulating Factor (rG-CSF) in H I V Patients 
with Zidovudine Related Neutropenia 
N.CLUMECK, S.D.WIT, P.HERMANS, P.FRANCHIOLY, and B.SOMMEREIJNS 353 
Effects of Granulocyte-Colony-Stimulating Factor in Neutropenic AIDS-Patients 
F . - D . G O E B E L , J .R .BOGNER, A .MATUSCHKE, B.HEINRICH, and U.KRONAWITTER ·· 357 
The Clinical Use of RHG-CSF for Malignant Lymphomas 
A . O Y A M A , H . S U Z U K I , M . O G U R A , Y . A R I Y O S H I , and S.ASANO 361 
A Randomised Vehicle Controlled Multicenter Dose Finding Phase Π . Study of 
Glycosylated rhuG-CSF in 121 Patients after Bone Marrow Transplantation 
J.H.SCARFFE 365 
G-CSF Mobilised Progenitor Cells in Autologous Transplantation: IN VITRO 
and IN VIVO Aspects 
C . G . B E G L E Y , E . D E L U C A , P .A.ROWLINGS, J.SZER, D . W A T S O N , C.JUTTNER, 
G . MORSTYN, R.M.FOX, and W.SHERIDAN 368 
Symposium @ Recent Advances in Thiamin Research 
Introductory Remarks 
C.J .GUBLER 372 
— 6 — 
Thiamin Transport in Yeast and Some Aspects of Its Regulation 
A.IWASHIMA, Y . K A W A S A K I , K . N O S A K A , and H.NISHIMURA 375 
Some Aspects of Thiamin Transport in Mammals 
G. R I N D ι 379 
Thiamin Triphosphate Synthesis in Animals 
T . K A W A S A K I 383 
Thiamin Triphosphatase and Conducting Sites 
Ε . SCHÖFFEN ι ELS 387 
Thiamin Pyrophosphate Binding Mechanism and the Function of the 
Aminopyrimidine Part 
A.SCHELLENBERGER 392 
Molecular Genetic Aspects of Human Pyruvate Dehydrogenase and Its Defect 
K . K O I K E , Y . U R A T A , and S.GOTO 397 
Thiamin and Alzheimer's Disease 
J.P.BLASS, K . - F . R . S H E U , A.J .L .COOPER, E . H . J U N G and G . E . G I B S O N 401 
Symposium © Recent Advances in Vitamin Κ Research 
Specificity of the Vitamin Κ and Glutamyl Binding Sites of the Liver Microsomal 
/-Glutamyl Carboxylase 
J .W.SUTTIE, C.P.GROSSMAN, and M . E . B E N T O N 405 
Pathogenesis of Vitamin Κ Deficiency in Newborn Infants 
A.SHIRAHATA, and N . A R I Y O S H I 409 
Comparative Aspects of Human Vitamin Κ Metabolism and Nutriture 
M.J.SHEARER, R . V . K R I E S , and J.SAUPE 4 1 3 
Serum and Liver Concentrations of Vitamin Κ in Surgical Patients 
H . Tanimura, and T.Tsuji 4 1 7 
Pathogenesis of Hypoprothrombinemia Induced by Antibiotics 
H . O B A T A , B . I I Z U K A , and K . U C H I D A 421 
The Roles of Intestinal Flora and Intestinal Function on Vitamin Κ Metabolism 
S.KIMURA, H . S A T O H , and M . K O M A I 425 
Symposium (Q) Bioavailability of Vitamins 
Bioavailability of Vitamins - An Overview 
M . M I N O , A . M U R A T A , K . Y A S U D A , and Y J T O K A W A 429 
Changes in Plasma Levels of Vitamin D and Its Metabolites in Healthy Subjects 
after Oral Administration of Vitamin D2 
T . K O B A Y A S H I , S . M A S U D A , T . O K A N O , H . O T S U K A , M . M A T S U O K A , M . K I T A G A W A , 
M . M I N O , M . K I M U R A , and Y . I T O K A W A 434 
Blood Levels and Urinary Excretion of Thiamin and Riboflavin during Oral 
Administration of Multivitamin Tablets to Healthy Adults 
Y . l T O K A W A , M . K l M U R A , K .NlSHINO, M . M l N O , M . K l T A G A W A , M . M A T S U O K A , 
and H .OTSUKA 438 
Some Considerations in the Pharmacokinetic Analysis of Vitamins 
N . K I T AMOR ι 442 
Vitamin C Bioavailability 
M . M A Y E R S O H N 446 
Symposium © Recent Topics in Vitamins in Biological Oxidation 
Mammalian Flavokinase and Fad Synthetase: Functions of Divalent Metal Ions 
and Arginyl Residues in the Anionic Substrate Sites 
H . N A K A N O , H . A . H A R T M A N , and D . B . M C C O R M I C K 450 
One- and Two-Electron Oxidation-Reduction Properties of Lipoamide Dehydrogenase 
Y . B A N D O , and K . A K I 453 
The Lipoyl Domain and Its Role in Thiamin Diphosphate-Dependent Oxidative 
Decarboxylation 
R . N . P E R H A M , A.BORGES, F . D A R D E L , L . D . G R A H A M , C . F . H A W K I N S , E . D . L A U E 
and L.C.PACKMAN 457 
Chemical Spectroscopic and Crystallographic Studies of UDP-Galactose 4-Epimerase 
from Escherichia coli 
P . A . F R E Y , A . J . B A U E R , J . L . V A N H O O K E , J . M . K O N O P K A , I . R A Y M E N T , 
and H . M . H O L D E N 461 
Structure and Function of Thermostable Amino Acid Dehydrogenases 
N . E S A K I , T .OHSH IMA , and K . S O D A 465 
Symposium ® Recent Advances in Vitamin A and Carotenoids 
Recent Advances in Carotenoid Studies - Metabolisms and Bioactivities — 
W . M I K I 469 
Function of Vitamin A in Normal and Malignant Leukocytes 
R.BLOMHOFF, B.SKREDE, H . K . B L O M H O F F , and K . R . N O R U M 473 
Retinoid Status and RARs Expression 
S . K A T O , H . M A N O , R . K O J I M A , Y .YOSHIZAWA, and S.MASUSHIGE 477 
Morphogenetic Roles of Retinoic Acid 
S.NOJI , T . N O H N O , E . K O Y A M A , H . I D E , S.TANIGUCHI, and T .SAITO 4 8 1 
Retinoic Acid Regulates the Expression of a New Heparin Binding Growth 
Differentiation Factor 
T . M U R A M A T S U 485 
Neuronal Differentiation of Human Neuroblastoma Cells by Retinoid 
T.SUGIMOTO, Y . H O R I I , T . S A W A D A , S.FUSHIKI, Y . S U Z U K I , and O . T A G A Y A 488 
— 8 — 
Symposium @ The Biopterin System : Recent Advances 
Novel Aspects of Metabolism and Function of Tetrahydrobiopterin 
S . K A U F M A N 492 
Role of Enzymes in Tetrahydrobiopterin Biosynthesis: Computer Analysis 
of the Sequential Reaction of the Last Step 
S . K A T O H , T .SUEOKA, and H . H I K J T A 497 
7-Substituted Pterins: Formation and Occurence 
H . - C H . C U R T I U S , C .ADLER, C.HEIZMANN, N . B L A U , I .REBRIN, and S.GHISLA, 501 
Neurotransmitter Releasing Action of 6R-Tetrahydrobiopterin 
K . K O S H I M U R A , T . O H U E , Y . W A T A N A B E , and S . M I W A 505 
6R-Tetrahydrobiopterin Biosynthesis: Structures of Rat and Human Sepiapterin 
Reductase 
T . N A G A T S U , H.ICHINOSE, S . K A T O H , K .FUJITA, and K . T I T A N I 510 
Symposium © Zinc as a Biofactor in Basic and Clinical Medicine 
Zinc: Brain Maturation and Function 
H . H . S A N D S T E A D 514 
Zinc Status in Proliferative Response of Τ Lymphocytes 
M . O H S A W A , F.OTSUKA, and S.SUGIZAKI 518 
Role of Zinc as an Activator of Bone Formation 
M . Y A M A G U C H I 522 
Zinc Status in Liver and Gastrointestinal Diseases 
Y . A R A K A W A , K . S U Z U K I , and S .TAKEUCHI 526 
Role of Zinc in Surgical Nutrition 
R . N E Z U , Y . T A K A G I , and A . O K A D A 530 
Zinc in Pediatric Surgery 
S.SUITA 534 
Symposium @ Free Radical Pathology and Antioxidants 
Free Radical Pathology and Antioxidants: Overview 
E . N I K I · 538 
Free Radical-Induced Biological Damage and the Critical Roles of Vitamin A , 
Vitamin C, Vitamin D and Vitamin Ε and of Copper, Iron, Selenium 
and Zinc. 
R . L . W I L L S O N 541 
Theoretical Basis for Antioxidant Action in Disease Prevention 
A . T . D I P L O C K 545 
The Mode of Action of Lipid-Soluble Antioxidants in Biological Membranes. 
Relationship between the Effects of Ubiquinol and Vitamin Ε as Inhibitors 
of Lipid Peroxidation in Submitochondrial Particles 
L.ERNSTER, P.FORSMARK, and K.NORDENBRAND 548 
— 9 
Antioxidant Function of Coenzyme Q 
T . K A W A S A K I 552 
Antioxidants in Gastric Mucosal Injury 
T.YOSHIKAWA, S .TAKAHASHI , Y . N A I T O , and M . K O N D O 556 
Beta-Carotene and Disease Prevention 
R . M U G G L I 560 
Future Prospects 
O . I G A R A S H I 564 
Symposium ® Biogenic Amines in Nervous Systems 
Introductory Remarks ; Biogenic Amines in Nervous Systems 
H . W A D A , and M . O K A 568 
Structure of Monoaminergic Neuron Systems in the Brain 
N . I N A G A K I , A . Y A M A T O D A N I , H . F U K U I , and H . W A D A 569 
Brain Histamine: Psychoneuroimmune Regulator in Physiological 
and Pathological Conditions 
R.CACABELOS 573 
Diurnal Monoamine Variation in Young and Old Rats: A Microdialysis Study 
A . S A N O , Κ .Αοι ,Τ .Αζ ι 564 
Introductory Remarks ; Biogenic Amines in Nervous Systems 
H . W A D A , and M . O K A * 568 
Structure of Monoaminergic Neuron Systems in the Brain 
N . I N A G A K I , A . Y A M A T O D A N I , H . F U K U I , and H . W A D A 570 
Brain Histamine: Psychoneuroimmune Regulator in Physiological 
and Pathological Conditions 
R.CACABELOS 573 
Diurnal Monoamine Variation in Young and Old Rats: A Microdialysis Study 
A . S A N O , K . A O I , T . A Z E K A W A , H.SEI, H.SENO, and Y . M O R I T A 577 
Imaging of Neurotransmitter Receptors in the Living Human Brain 
by Positron Emission Tomography (PET) 
K . Y A N A I , T . W A T A N A B E , M . I T O H , andT.lDO 581 
Thiamine Responsive Pyruvate Dehydrogenase Deficiency 
K . N A R I S A W A , H .ENDO, S .MIYABAYASHI , and K . T A D A 585 
Pyridoxine Responsive and Unresponsive Homocystinuria 
J.P.KRAUS, and V . K O Z I C H 589 
Vitamin Β12 (Cbl)-Responsive Disorders 
D.S.ROSENBLATT 593 
Neonatal Form of Biotin-responsive Multiple Carboxylase Deficiency 
Y . S U Z U K I , Y . C H I B A , K . T A D A , and K . N A R I S A W A 597 
Biopterin-Responsive Hyperphenylalaninemia 
S .KAUFMAN 601 
— 10 — 
S-ll-B-2b Effects of Granulocyte-Colony-Stimulating Factor in 
Neutropenie AIDS-Patients 
F . - D . G O E B E L , J . R . B O G N E R , Α . Μ ATUSCH K E , 
B . H E I N R I C H , and U . K R O N A W I T T E R 
M e d i z i n i s c h e P o l i k l i n i k , Universität München, P e t t e n k o f e r s t r . 8a, 
8000 München 2, Germany 
I . INTRODUCTION 
Azid o t h y m i d i n i s the on l y a n t i v i r a l s u b s t a n c e , which has been 
demonstrated to i n c r e a s e the l i f e span and reduce both i n c i d e n c e 
and c o m p l i c a t i o n s of o p p o r t u n i s t i c i n f e c t i o n s i n H I V - i n f e c t e d 
p a t i e n t s ( 1 , 2 , 3 ) . G a n c y c l o v i r (DHPG) tre a t m e n t i s r e q u i r e d f o r 
cy t o m e g a l o v i r u s induced d i s e a s e ( 4 ) . I n both regimen n e u t r o p e n i a 
i s the most common cause f o r c e s s a t i o n of th e r a p y . G r a n u l o c y t e 
c o l o n y - s t i m u l a t i n g f a c t o r (G-CSF) i n c r e a s e s the number of granulo 
c y t e s by s e l e c t i v e s t i m u l a t i o n of the stem c e l l s of the gr a n u l o -
p o e s i s ( 5 ) . We performed a p l a c e b o - c o n t r o l l e d , d o s e - e s c a l a t i n g 
study f o r AZT-induced n e u t r o p e n i a i n 10 p a t i e n t s w i t h G-CSF. 
A d d i t i o n a l 6 p a t i e n t s were t r e a t e d w i t h G-CSF f o r DHPG-induced 
n e u t r o p e n i a on a compassionate use b a s i s . 
I I . STUDY DESIGN 
AIDS p a t i e n t s w i t h a g r a n u l o c y t e count below 1000/μ1 were 
e l i g i b l e . I n the AZT group 2 p a t i e n t s each r e c e i v e d p l acebo, 
0.5, 2.0, 5.0, 10.0 ug/kg G-CSF 3ubcutaneously f o r 10 days. I n 
the DHPG group p a t i e n t s r e c e i v e d 5 jag/kg G-CSF f o r 6 up to 117 
days (mean 44 d a y s ) . 
V a l u e s g i v e n i n the t e x t a r e means + s t a n d a r d d e v i a t i o n . S t a t i s t i 
c a l a n a l y s i s was performed by Wilcoxon t e s t . 
I l l . R E S U L T S 
G r a n u l o c y t e s i n c r e a s e d i n a l l p a t i e n t s t r e a t e d w i t h G-CSF a t 
l e a s t to l e v e l s a l l o w i n g c o n t i n u a t i o n of the b a s i c t h e r a p y w i t h ­
out dose r e d u c t i o n . I n the AZT group no s i g n i f i c a n t change was 
seen under p l a c e b o . E i g h t hours a f t e r the f i r s t i n j e c t i o n of 
G-CSF, the mean g r a n u l o c y t e count had i n c r e a s e d from 997 + 
186/μ1 b e f o r e the i n j e c t i o n to 3811 + 2205/μ1 (ρ<0.025) i n the 
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AZT-group. The mean maximum of the g r a n u l o c y t e count r e a c h e d 
two peaks. I n a l l but one p a t i e n t the f i r s t peak o c c u r e d on day 
3 or 4; the second peak was rea c h e d between day 8 t o 10 and 
appeared t o be h i g h e r than the f i r s t one. The i n c r e a s e of g r a n u l 
c y t e s on the day a f t e r the f i r s t i n j e c t i o n appeared not t o be 
dose dependent, but the maximum increment of the g r a n u l o c y t e 
count showed a c l e a r c u t dose dependancy ( f i g u r e 1 ) . G-CSF was 
r e c e i v e d i n two ba t c h e s f o r 5 p a t i e n t s each. There was a remar­
k a b l e d i f f e r e n c e i n the g r a n u l o c y t e i n c r e a s e between those two 
batc h e s ( f i g u r e 2).Two days a f t e r G-CSF was stopped the number 
of g r a n u l o c y t e s s t a r t e d t o d e c l i n e . W i t h i n 2 weeks a f t e r d i s ­
c o n t i n u a t i o n 3 of 8 AZT p a t i e n t s had g r a n u l o c y t e count below 
1000/μ1. Treatment w i t h AZT had to be d i s c o n t i n u e d i n 5 p a t i e n t s 
w i t h i n 4 days a f t e r G-CSF was stopped. 
I n the DHPG group the mean g r a n u l o c y t e s i n c r e a s e d from 654 + 
260/μ1 b e f o r e the f i r s t i n j e c t i o n t o 2169 + 1480/μ1 one day l a t e 
The lymphocyte s u b s e t s and serum n e o p t e r i n l e v e l s were not a f f e c 
t e d by G-CSF. I n 7 p a t i e n t s t r e a t e d w i t h G-CSF and AZT p24 a n t i ­
gen was d e t e c t a b l e . I n 6 of them p24 a n t i g e n l e v e l s i n c r e a s e d 
from 2 6 + 2 3 pg/ml a t e n t r y to 33 + 29 pg/ml on day 11 i n the 
avarage. I n 1 p a t i e n t the p24 a n t i g e n d e c r e a s e d from 3.4 pg/ml 
to 1.4 pg/ml. 
B e t a - 2 - m i c r o g l o b u l i n l e v e l s i n c r e a s e d from 4.0 + 1.1 mg/1 on day 
1 t o 5,5 + 2.3 mg/1 on day 4 (p-cO.025) i n the AZT group. Seven 
days a f t e r G-CSF was stopped b e t a - 2 - m i c r o g l o b u l i n l e v e l s had 
dec r e a s e d t o 3.7 + 1.1 mg/1. 
IV.SIDE-EFFECTS 
A drop of thrombocytes was observed i n a l l p a t i e n t s t r e a t e d 
s i m u l t a n e o u s l y w i t h G-CSF and AZT. On day 1 the mean p l a t e l e t 
count was 164 + 6 0 x l 0 3 /μΐ. P l a t e l e t s s t a r t e d to d e c l i n e on 
day 2 and rea c h e d the minimum between day 11 and 14. The mean 
minimum was 100 + 48χ10 3/μ1. P l a t e l e t s d e c r e a s e d between 17 % 
and 56 % of the b a s i c v a l u e . The d e c r e a s e was not r e l a t e d to the 
dose of G-CSF. I n c o n t r a s t , o n l y 2 of the 6 p a t i e n t s t r e a t e d 
w i t h G-CSF and DHPG developed a d e c l i n e of the p l a t e l e t s , 
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whereas the mean of the minimum of the p l a t e l e t count of a l l 
s i x p a t i e n t s even i n c r e a s e d . 
One p a t i e n t of G-CSF and AZT e x p e r i e n c e d a s k i n r a s h a f t e r 4 days, 
not r e a p p e a r i n g on r e c h a l l e n g e on day 7. No f u r t h e r adverse 
r e a c t i o n s were observed. 
V. CONCLUSIONS 
G-CSF appears to be v a l u a b l e s u b s t a n c e i n AIDS p a t i e n t s 
w i t h n e u t r o p e n i a . However, i t s h o u l d be c o n s i d e r e d w i t h c a u t i o n 
i n AIDS p a t i e n t s w i t h thrombocytopenia. The e f f i c a c y of long 
term t r e a t m e n t remains t o be determined. 
Even s t r o n g l y m y e l o t o x i c drugs can be a d m i n i s t e r e d , i f n e c e s s a r y , 
when G-CSF i s a v a i l a b l e . The i n f l u e n c e of G-CSF on H I V - r e p l i -
c a t i o n i n v i v o has to be e l u c i d a t e d . 
Our p r e l i m i n a r y r e s u l t s emphasize the need f o r a d d i t i o n a l 
s t u d i e s w i t h G-CSF i n AIDS p a t i e n t s w i t h n e u t r o p e n i a f o r 
v a r i o u s r e a s o n s . 
granulocytes [/μ\] 
2 patients each received the same dose of G-CSF 
F i g u r e 1: E f f e c t s of the dose of G-CSF a d m i n i s t e r e d on the 
g r a n u l o c y t e c o u n t s . i n AIDS p a t i e n t s t r e a t e d w i t h 
z i d o v u d i n e . 









• mean granulocyte counts of 4 patients treated with batch 1 
• mean granulocyte counts of 4 patients treated with batch 2 
25 days 
F i g u r e 2: E f f e c t s of two d i f f e r e n t b a t c h e s of G-CSF on the 
gr a n u l o c y t e c o u n t s i n A I D S - p a t i e n t s on Zido v u d i n e . 
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